Thursday, December 20, 2018 1:10:32 PM
A nation of sheep will beget a government of wolves. — Edward R. Murrow
Recent MNKD News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2025 10:09:57 PM
- MannKind Expands Executive Leadership Team • GlobeNewswire Inc. • 01/06/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 12:00:30 PM
- MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash • GlobeNewswire Inc. • 12/18/2024 12:00:00 PM
- MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®) • GlobeNewswire Inc. • 12/16/2024 11:05:00 AM
- CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India • GlobeNewswire Inc. • 12/11/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/26/2024 02:30:07 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/22/2024 09:08:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 02:30:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/15/2024 09:01:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2024 02:30:04 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:06:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:05:13 PM
- MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/07/2024 09:02:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/06/2024 09:04:14 PM
- MannKind to Present at 2024 UBS Healthcare Conference • GlobeNewswire Inc. • 11/05/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 02:00:03 AM
- MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases • GlobeNewswire Inc. • 11/04/2024 11:05:00 AM
- MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024 • GlobeNewswire Inc. • 10/31/2024 08:05:00 PM
- More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®) • GlobeNewswire Inc. • 09/30/2024 10:00:00 AM
- MannKind Announces Clearance from PMDA to Initiate Phase 3 Clinical Trial (ICoN-1) in Japan Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease • GlobeNewswire Inc. • 09/18/2024 10:15:00 AM
- MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare Conference • GlobeNewswire Inc. • 09/10/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 01:11:49 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:25:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 08:35:07 PM
Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing • BLO • Jan 24, 2025 8:49 AM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM